Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VAISHALI PHARMA    MYLAN
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
MYLAN
Dec-18
VAISHALI PHARMA /
MYLAN
5-Yr Chart
Click to enlarge
High Rs1943,967-   
Low Rs642,184-   
Sales per share (Unadj.) Rs66.01,825.4-  
Earnings per share (Unadj.) Rs6.349.6-  
Cash flow per share (Unadj.) Rs6.7391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.31,974.7-  
Shares outstanding (eoy) m10.55514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.7 116.0%   
Avg P/E ratio x20.662.0 33.2%  
P/CF ratio (eoy) x19.17.9 243.7%  
Price / Book Value ratio x4.11.6 265.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,3611,582,214 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m130-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m697939,158 0.1%  
Other income Rs m220-   
Total revenues Rs m719939,158 0.1%   
Gross profit Rs m94243,019 0.0%  
Depreciation Rs m5175,847 0.0%   
Interest Rs m2345,170 0.0%   
Profit before tax Rs m8822,002 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m22-3,500 -0.6%   
Profit after tax Rs m6625,502 0.3%  
Gross profit margin %13.525.9 52.0%  
Effective tax rate %25.4-15.9 -159.4%   
Net profit margin %9.52.7 349.1%  
BALANCE SHEET DATA
Current assets Rs m727524,425 0.1%   
Current liabilities Rs m321382,364 0.1%   
Net working cap to sales %58.315.1 385.3%  
Current ratio x2.31.4 165.2%  
Inventory Days Days1884 21.5%  
Debtors Days Days2,80993 3,010.1%  
Net fixed assets Rs m61182,181 0.0%   
Share capital Rs m105500 21.1%   
"Free" reserves Rs m2240-   
Net worth Rs m3301,015,998 0.0%   
Long term debt Rs m521,096,588 0.0%   
Total assets Rs m7882,725,301 0.0%  
Interest coverage x4.91.5 331.0%   
Debt to equity ratio x0.21.1 14.7%  
Sales to assets ratio x0.90.3 256.7%   
Return on assets %11.22.6 433.8%  
Return on equity %20.02.5 797.9%  
Return on capital %29.13.2 914.1%  
Exports to sales %25.20-   
Imports to sales %7.80-   
Net fx Rs m1210-   
CASH FLOW
From Operations Rs m11195,157 0.0%  
From Investments Rs m3-100,875 -0.0%  
From Financial Activity Rs m-17-90,916 0.0%  
Net Cashflow Rs m-41,617 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare VAISHALI PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare VAISHALI PHARMA With: FREDUN PHARMA  BIOFIL CHEMICALS  WINDLAS BIOTECH  CONCORD DRUGS  JENBURKT PH.  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.